The Study
Effect of a Diet Supplemented with Marine Omega-3 Fatty Acids on Inflammatory Markers in Subjects with Obesity: A Randomized Active Placebo-Controlled Trial
This study is like a fair test where two groups of people ate the same diet, but one group got fish oil pills and the other got fake pills. After 8 weeks, the fish oil group had better blood markers for inflammation. But we can't say it 'cures' inflammation — just that it might help a little in this group.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Scientists gave obese people either fish oil pills or fake pills made from flaxseed, while everyone ate the same healthy, low-calorie diet for 8 weeks.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 581 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The inflammation changes are biologically meaningful — Resolvin D1 helps stop inflammation, so this suggests fish oil helps the body heal itself.
- 2But it didn't make people lose more weight or improve insulin better than diet alone.
- 3People who took fish oil had 129 pg/mL more Resolvin D1, 1.4 pg/mL more IL-10, and less IL-6 and MCP-1 — all signs their bodies were better at calming inflammation.
- 4Men lost more belly fat than women in the fish oil group.
- 5But insulin and overall body fat didn't improve more than the fake pill group.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Healthcare
Year
2025
Authors
J. Torres-Vanegas, R. Rodríguez-Echevarría, W. Campos-Pérez, S. C. Rodríguez-Reyes, Samantha Desireé Reyes-Pérez, M. Pérez-Robles, Erika Martínez-López
Related Content
Claims (6)
Consuming omega-3 fatty acids lowers levels of IL-6, TNF-alpha, and CRP in people with metabolic or cardiovascular disease after physical exertion.
In obese adults, taking marine omega-3 supplements for 8 weeks does not improve insulin sensitivity more than taking a different type of omega-3 placebo, and both groups saw similar improvements, which means the change in insulin sensitivity was likely due to reduced calorie intake, not the omega-3 supplements.
In obese adults aged 25–50, taking 1.8 grams of marine omega-3 fatty acids daily for 8 weeks along with a diet low in n-6 fats increases Resolvin D1 and IL-10 in the blood while reducing IL-6 and MCP-1, compared to taking ALA.
In obese adults, eating a diet with a ratio of n-6 to n-3 fatty acids of 5:1 or lower increases marine omega-3 intake and decreases n-6 intake, resulting in a fatty acid profile associated with reduced inflammation.
Obese adults who consume a diet with a ratio of omega-6 to omega-3 fatty acids of 5:1 or lower have a lower rate of abdominal fat accumulation, regardless of whether they take marine omega-3 supplements.
In obese adults, taking 1.8 grams per day of marine omega-3 fatty acids for 8 weeks does not reduce body fat or waist size more than a placebo on average, but men experience greater reductions in these measures than women.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.